Monocyte class switch and hyperinflammation characterise severe COVID-19 in type 2 diabetes
View ORCID ProfileFawaz Alzaid, Jean-Baptiste Julla, Marc Diedisheim, Charline Potier, Louis Potier, Gilberto Velho, Bénédicte Gaborit, Philippe Manivet, Stéphane Germain, Tiphaine Vidal-Trecan, Ronan Roussel, Jean-Pierre Riveline, Elise Dalmas, Nicolas Venteclef, Jean-François Gautier
doi: https://doi.org/10.1101/2020.06.02.20119909
Fawaz Alzaid
1Cordeliers Research Centre, INSERM, IMMEDIAB Laboratory, Sorbonne Université, Université de Paris, F-75006, Paris, France
Jean-Baptiste Julla
1Cordeliers Research Centre, INSERM, IMMEDIAB Laboratory, Sorbonne Université, Université de Paris, F-75006, Paris, France
2Department of Diabetes, Clinical Investigation Centre (CIC-9504), Lariboisière Hospital, Assistance Publique – Hôpitaux de Paris, Paris, France
Marc Diedisheim
1Cordeliers Research Centre, INSERM, IMMEDIAB Laboratory, Sorbonne Université, Université de Paris, F-75006, Paris, France
3Department of diabetology, Cochin Hospital, Assistance Publique Hôpitaux de Paris, Université de Paris, Paris, France
Charline Potier
1Cordeliers Research Centre, INSERM, IMMEDIAB Laboratory, Sorbonne Université, Université de Paris, F-75006, Paris, France
Louis Potier
1Cordeliers Research Centre, INSERM, IMMEDIAB Laboratory, Sorbonne Université, Université de Paris, F-75006, Paris, France
4Department of Diabetology, Endocrinology and Nutrition, Bichat Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France
Gilberto Velho
1Cordeliers Research Centre, INSERM, IMMEDIAB Laboratory, Sorbonne Université, Université de Paris, F-75006, Paris, France
Bénédicte Gaborit
5Aix Marseille University, INSERM, INRA, C2VN, Marseille, France. Endocrinology, Metabolic Diseases and Nutrition Department, Assistance Publique Hôpitaux de Marseille, France
Philippe Manivet
6Centre de Ressources Biologique « biobank Lariboisière », BB-0033-00064. APHP.Nord, Université de Paris, Paris Diderot. Hôpital Lariboisière, Paris 10, France
Stéphane Germain
7Center for Interdisciplinary Research in Biology (CIRB), College de France – Centre National de la Recherche Scientifique (CNRS), Institut National de la Santé et de la Recherche Médicale (INSERM), Paris Sciences et Lettres (PSL) Research University, Paris, France
Tiphaine Vidal-Trecan
2Department of Diabetes, Clinical Investigation Centre (CIC-9504), Lariboisière Hospital, Assistance Publique – Hôpitaux de Paris, Paris, France
Ronan Roussel
1Cordeliers Research Centre, INSERM, IMMEDIAB Laboratory, Sorbonne Université, Université de Paris, F-75006, Paris, France
4Department of Diabetology, Endocrinology and Nutrition, Bichat Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France
Jean-Pierre Riveline
1Cordeliers Research Centre, INSERM, IMMEDIAB Laboratory, Sorbonne Université, Université de Paris, F-75006, Paris, France
2Department of Diabetes, Clinical Investigation Centre (CIC-9504), Lariboisière Hospital, Assistance Publique – Hôpitaux de Paris, Paris, France
Elise Dalmas
1Cordeliers Research Centre, INSERM, IMMEDIAB Laboratory, Sorbonne Université, Université de Paris, F-75006, Paris, France
Nicolas Venteclef
1Cordeliers Research Centre, INSERM, IMMEDIAB Laboratory, Sorbonne Université, Université de Paris, F-75006, Paris, France
Jean-François Gautier
1Cordeliers Research Centre, INSERM, IMMEDIAB Laboratory, Sorbonne Université, Université de Paris, F-75006, Paris, France
2Department of Diabetes, Clinical Investigation Centre (CIC-9504), Lariboisière Hospital, Assistance Publique – Hôpitaux de Paris, Paris, France
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted June 02, 2020.
Monocyte class switch and hyperinflammation characterise severe COVID-19 in type 2 diabetes
Fawaz Alzaid, Jean-Baptiste Julla, Marc Diedisheim, Charline Potier, Louis Potier, Gilberto Velho, Bénédicte Gaborit, Philippe Manivet, Stéphane Germain, Tiphaine Vidal-Trecan, Ronan Roussel, Jean-Pierre Riveline, Elise Dalmas, Nicolas Venteclef, Jean-François Gautier
medRxiv 2020.06.02.20119909; doi: https://doi.org/10.1101/2020.06.02.20119909
Monocyte class switch and hyperinflammation characterise severe COVID-19 in type 2 diabetes
Fawaz Alzaid, Jean-Baptiste Julla, Marc Diedisheim, Charline Potier, Louis Potier, Gilberto Velho, Bénédicte Gaborit, Philippe Manivet, Stéphane Germain, Tiphaine Vidal-Trecan, Ronan Roussel, Jean-Pierre Riveline, Elise Dalmas, Nicolas Venteclef, Jean-François Gautier
medRxiv 2020.06.02.20119909; doi: https://doi.org/10.1101/2020.06.02.20119909
Subject Areas
- Addiction Medicine (330)
- Allergy and Immunology (652)
- Anesthesia (174)
- Cardiovascular Medicine (2527)
- Dermatology (211)
- Emergency Medicine (387)
- Epidemiology (12005)
- Forensic Medicine (10)
- Gastroenterology (721)
- Genetic and Genomic Medicine (3920)
- Geriatric Medicine (368)
- Health Economics (655)
- Health Informatics (2536)
- Health Policy (978)
- Hematology (353)
- HIV/AIDS (814)
- Medical Education (390)
- Medical Ethics (106)
- Nephrology (420)
- Neurology (3681)
- Nursing (205)
- Nutrition (548)
- Oncology (1915)
- Ophthalmology (558)
- Orthopedics (231)
- Otolaryngology (299)
- Pain Medicine (244)
- Palliative Medicine (71)
- Pathology (466)
- Pediatrics (1078)
- Primary Care Research (436)
- Public and Global Health (6354)
- Radiology and Imaging (1342)
- Respiratory Medicine (847)
- Rheumatology (389)
- Sports Medicine (336)
- Surgery (427)
- Toxicology (51)
- Transplantation (180)
- Urology (157)